National Scleroderma Foundation is ranked among medical research organizations in Danvers, MA, with an America's Best Score of 66 out of 100, based on its 2025 Form 990.
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$6,628,652Fiscal year 2025
Expenses$6,783,274Fiscal year 2025
Total assets$11,259,408Fiscal year 2025
Total liabilities$2,926,793Fiscal year 2025
Fiscal year ending June2025
Revenue$6,628,652
Expenses$6,783,274
Net income−$154,622
Net assets$8,332,615
Notable sources of revenue
Percent of total revenue
Contributions
$5,597,175
84.4%
Program services
$0
0.0%
Investment income
$1,165,141
17.6%
Other (net)
−$133,664
−2.0%
Assets / debt
Total assets
$11,259,408
Total liabilities
$2,926,793
Net assets
$8,332,615
Compensation
Not in our extract for this year.
Fiscal year ending June2024
Revenue$4,941,722
Expenses$6,956,852
Net income−$2,015,130
Net assets$8,353,197
Notable sources of revenue
Percent of total revenue
Contributions
$3,912,611
79.2%
Program services
$0
0.0%
Investment income
$970,638
19.6%
Other (net)
$58,473
1.2%
Assets / debt
Total assets
$11,162,466
Total liabilities
$2,809,269
Net assets
$8,353,197
Compensation
Not in our extract for this year.
Fiscal year ending June2023
Revenue$6,915,898
Expenses$6,461,742
Net income$454,156
Net assets$9,811,236
Notable sources of revenue
Percent of total revenue
Contributions
$6,057,608
87.6%
Program services
$0
0.0%
Investment income
$476,604
6.9%
Other (net)
$381,686
5.5%
Assets / debt
Total assets
$12,897,422
Total liabilities
$3,086,186
Net assets
$9,811,236
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?